Clover Corporation Ltd
ASX:CLV
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.36
0.88
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CLV stock under the Base Case scenario is 0.816 AUD. Compared to the current market price of 0.495 AUD, Clover Corporation Ltd is Undervalued by 39%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Clover Corporation Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CLV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Clover Corporation Ltd
Balance Sheet Decomposition
Clover Corporation Ltd
Current Assets | 56.9m |
Cash & Short-Term Investments | 12.3m |
Receivables | 13.7m |
Other Current Assets | 30.9m |
Non-Current Assets | 27.5m |
Long-Term Investments | 11.3m |
PP&E | 12.5m |
Intangibles | 1.9m |
Other Non-Current Assets | 1.8m |
Current Liabilities | 9.8m |
Accounts Payable | 5.1m |
Accrued Liabilities | 898k |
Other Current Liabilities | 3.8m |
Non-Current Liabilities | 7.5m |
Long-Term Debt | 6.5m |
Other Non-Current Liabilities | 950k |
Earnings Waterfall
Clover Corporation Ltd
Revenue
|
62.2m
AUD
|
Cost of Revenue
|
-45.3m
AUD
|
Gross Profit
|
16.9m
AUD
|
Operating Expenses
|
-13.7m
AUD
|
Operating Income
|
3.1m
AUD
|
Other Expenses
|
-1.6m
AUD
|
Net Income
|
1.5m
AUD
|
Free Cash Flow Analysis
Clover Corporation Ltd
AUD | |
Free Cash Flow | AUD |
CLV Profitability Score
Profitability Due Diligence
Clover Corporation Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Clover Corporation Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
CLV Solvency Score
Solvency Due Diligence
Clover Corporation Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Clover Corporation Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CLV Price Targets Summary
Clover Corporation Ltd
According to Wall Street analysts, the average 1-year price target for CLV is 0.791 AUD with a low forecast of 0.606 AUD and a high forecast of 0.998 AUD.
Dividends
Current shareholder yield for CLV is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company is headquartered in Melbourne, Victoria and currently employs 53 full-time employees. The Company’s geographical segments include Australia/New Zealand, Asia, Europe and America. The firm is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. The company focuses on developing nutrients for use in foods or as nutritional supplements. The firm provides lipid-based ingredients for the food industry. The company focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. The company uses tuna oil, which has docosahexaenoic acid (DHA) for brain, nerve and eye tissue development in babies and infants. The company has a technology license for the encapsulation of marine and algal oils. The firm has a manufacturing plant for tuna oils and related products in Altona, Victoria.
Contact
IPO
Employees
Officers
The intrinsic value of one CLV stock under the Base Case scenario is 0.816 AUD.
Compared to the current market price of 0.495 AUD, Clover Corporation Ltd is Undervalued by 39%.